Clinical Trial Update: Examining Genetic Differences Among People With 21-Hydroxylase Deficiency [NA]

View source ↗

Summary

A completed clinical trial update examining genetic differences among individuals with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Snippet

Sponsor: Maria I. New | Conditions: 21-hydroxylase Deficiency | NA | Status: COMPLETED